Novagenix Bioanalytical Drug R&D Center Report issue

For profit Phase 1
Founded: ankara Turkey (1999)

Organization Overview

First Clinical Trial
2019
NCT04639869
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Novagenix Bioanalytical Drug R&D Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malnutrition (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 8
  • # of Trial APIs: 5